Cas No.: | 242138-07-4 |
pH value: | Corresponds to reference standard: PASS |
Non-reduced CE-SDS: | 98.6% |
SEC-HPLC: | 99.3% |
Isoelectric Point: | Corresponds to reference standard:PASS |
Bacterial Endotoxins Test: | <1 EU/ml |
Exogenous Residual DNA: | 1 pg/mg |
Residual protein A: | <1 ng/mg |
Biological Activity: | Compared with standard, the range of biological activity is 103% |
Osmolality: | Corresponds to reference standard: PASS |
Peptide mapping: | Corresponds to reference standard: PASS |
N-terminal sequence: | Corresponds to reference standard:PASS |
Description: | Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E to treat an asthma attack. |